Effect on Blood Lipids and Haemostasis of a Supplement of Cod-Liver Oil, Rich in Eicosapentaenoic and Docosahexaenoic Acids, in Healthy Young Men

1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A an...

Full description

Saved in:
Bibliographic Details
Published inClinical science (1979) Vol. 61; no. 3; pp. 317 - 324
Main Authors Sanders, T. A. B., Vickers, Marguerite, Haines, A. P.
Format Journal Article
LanguageEnglish
Published England 01.09.1981
Subjects
Online AccessGet full text
ISSN0143-5221
1470-8736
DOI10.1042/cs0610317

Cover

Abstract 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5′-pyrophosphate (ADP) was also studied. 2. The proportions of 20:5ω3 and 22: 6ω3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of ω6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.
AbstractList 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.
Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1 multiplied by 8 g of eicosapentaenoic acid (20:5 omega 3 and 2 multiplied by 2 g of docosahexaenoic acid (22:6 omega 3). The proportions of 20:5 omega 3 and 22:6 omega 3 in platelet and erthrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement.
1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.
1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5′-pyrophosphate (ADP) was also studied. 2. The proportions of 20:5ω3 and 22: 6ω3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of ω6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.
Author Sanders, T. A. B.
Haines, A. P.
Vickers, Marguerite
Author_xml – sequence: 1
  givenname: T. A. B.
  surname: Sanders
  fullname: Sanders, T. A. B.
  organization: Department of Nutrition, Queen Elizabeth College, University of London
– sequence: 2
  givenname: Marguerite
  surname: Vickers
  fullname: Vickers, Marguerite
  organization: MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex, U.K
– sequence: 3
  givenname: A. P.
  surname: Haines
  fullname: Haines, A. P.
  organization: MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex, U.K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6266735$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFO3DAQhi1EBbvQAw-A5FOlSgQ8duIkR9huWaStkEp76ClynAnrKrFD7FTlMfrG9cKKA0JCcxjNzDf_SP_Myb51Fgk5AXYOLOUX2jMJTEC-R2aQ5iwpciH3yYxBKpKMczgkc-9_M8ZFjANyILmUuchm5N-ybVEH6iy96pxr6NoMpvFU2YauFPbOB-WNp66lit5Nw9BhjzZs64VrkrX5gyO9Nd0Z_W70hhpLl0Y7r4YIKbTO6CepL27b3ODfXe9SxyNnW3yFqgubR_rLTfaefkN7TD60qvP4cZePyM-vyx-LVbK-vb5ZXK4TzUsekhx00UBaQCkLkdeprOu6BNkq2fBoBQoGnCvMkAOkNc9R8bSsS1G0aS1y3ooj8ulZdxjdw4Q-VL3xGrtOWXSTr6I9BTCAd0HIIpmVRQRPd-BU99hUw2h6NT5WO7Pj_PPzXI_O-xHbFwJYtf1j9fLHyF68YrUJKhhnw6hM98bGfx9cnd4
CitedBy_id crossref_primary_10_1016_S0022_2275_20_36960_1
crossref_primary_10_1007_BF01711937
crossref_primary_10_1016_S0955_2863_01_00167_X
crossref_primary_10_1079_BJN19920123
crossref_primary_10_1016_0026_0495_89_90117_0
crossref_primary_10_1016_0163_7827_86_90005_6
crossref_primary_10_1016_0261_5614_90_90022_K
crossref_primary_10_1079_BJN19840009
crossref_primary_10_1023_A_1026552405042
crossref_primary_10_1111_j_1550_7408_2000_tb00002_x
crossref_primary_10_1111_j_1365_2796_1990_tb00170_x
crossref_primary_10_1016_0165_1838_88_90112_9
crossref_primary_10_1093_ajcn_52_1_120
crossref_primary_10_1093_ajcn_67_3_542S
crossref_primary_10_1038_307165a0
crossref_primary_10_1111_j_1365_2796_1990_tb00280_x
crossref_primary_10_1093_ajcn_54_2_326
crossref_primary_10_1136_bmj_293_6539_104
crossref_primary_10_1016_0005_2760_84_90209_1
crossref_primary_10_1016_S0022_2275_20_38424_8
crossref_primary_10_1155_2018_8261432
crossref_primary_10_1016_0021_9150_87_90067_0
crossref_primary_10_1161_01_ATV_17_12_3449
crossref_primary_10_1016_0006_2952_88_90218_3
crossref_primary_10_1002_ijc_2910400625
crossref_primary_10_1016_0306_9877_87_90071_5
crossref_primary_10_1016_0163_7827_86_90070_6
crossref_primary_10_1016_0049_3848_95_00152_H
crossref_primary_10_5657_kfas_2002_35_2_162
crossref_primary_10_1177_0148607197021005296
crossref_primary_10_1016_S0090_6980_85_80010_1
crossref_primary_10_1016_0021_9150_85_90106_6
crossref_primary_10_1016_j_plefa_2003_11_008
crossref_primary_10_1002_lipi_19880900302
crossref_primary_10_1016_0306_3623_90_90825_7
crossref_primary_10_1111_j_1525_1594_1991_tb00768_x
crossref_primary_10_1017_S1368980000000367
crossref_primary_10_1371_journal_pone_0035102
crossref_primary_10_1016_0021_9150_88_90101_3
crossref_primary_10_1016_S0952_3278_97_90421_X
crossref_primary_10_1093_ajcn_46_2_258
crossref_primary_10_1111_j_1365_4362_1990_tb03477_x
crossref_primary_10_3109_00365518409083785
crossref_primary_10_1007_BF00503896
crossref_primary_10_1016_0952_3278_90_90076_W
crossref_primary_10_1079_NRR2005113
crossref_primary_10_1079_PNS19870048
crossref_primary_10_1016_0306_3623_90_90908_5
crossref_primary_10_1016_S0140_6736_82_91650_6
crossref_primary_10_1093_ajcn_52_1_1
crossref_primary_10_1111_j_1365_2796_1989_tb01443_x
crossref_primary_10_1016_0002_9343_88_90007_1
crossref_primary_10_1007_BF02022993
crossref_primary_10_1056_NEJM198904203201603
crossref_primary_10_1080_00365518809085759
crossref_primary_10_1177_146642408410400409
crossref_primary_10_1016_0049_3848_90_90073_L
crossref_primary_10_1016_S0306_9877_96_90183_8
crossref_primary_10_1016_0005_2760_88_90121_X
crossref_primary_10_1016_S0006_291X_84_80193_X
crossref_primary_10_1054_mehy_1997_0684
crossref_primary_10_1007_BF01622227
crossref_primary_10_1007_BF02535987
crossref_primary_10_1111_j_1751_1097_1995_tb02383_x
crossref_primary_10_1016_0002_8703_87_90643_0
crossref_primary_10_1016_0049_3848_88_90054_0
crossref_primary_10_1079_BJN20051658
crossref_primary_10_1016_S0271_5317_87_80090_8
crossref_primary_10_1007_BF02534401
crossref_primary_10_1016_S0271_5317_05_80037_5
crossref_primary_10_1007_BF02536145
crossref_primary_10_1093_ajcn_65_5_1687S
crossref_primary_10_1093_ajcn_59_5_1117S
crossref_primary_10_1016_0049_3848_86_90101_5
crossref_primary_10_1093_ajcn_59_2_384
crossref_primary_10_1016_S0308_2261_18_30020_1
crossref_primary_10_1017_S002966519900052X
crossref_primary_10_1111_j_1476_5381_1982_tb09186_x
crossref_primary_10_1007_BF00496373
crossref_primary_10_1016_0021_9150_85_90021_8
crossref_primary_10_1016_S0140_6736_82_91651_8
crossref_primary_10_1007_BF02535644
crossref_primary_10_1016_0021_9150_85_90044_9
crossref_primary_10_1016_j_nutres_2004_04_008
crossref_primary_10_1016_0952_3278_94_90156_2
crossref_primary_10_1007_BF02535527
crossref_primary_10_1016_S0753_3322_02_00253_6
crossref_primary_10_1016_S0002_8223_21_01118_4
crossref_primary_10_1016_S0271_5317_85_80170_6
crossref_primary_10_1111_j_0954_6820_1986_tb03271_x
crossref_primary_10_1016_S0271_5317_05_80282_9
crossref_primary_10_1016_0005_2760_87_90160_3
crossref_primary_10_1111_j_1365_2125_1990_tb03764_x
crossref_primary_10_1016_S0272_6386_85_80063_9
crossref_primary_10_1016_0049_3848_91_90116_E
crossref_primary_10_1016_S0950_351X_05_80085_0
crossref_primary_10_1080_00365518209168395
crossref_primary_10_2903_j_efsa_2012_2815
crossref_primary_10_1016_S0140_6736_82_91649_X
crossref_primary_10_1016_0005_2760_86_90247_X
crossref_primary_10_1016_0005_2736_93_90216_M
crossref_primary_10_1161_JAHA_118_008757
crossref_primary_10_1111_j_1365_2621_2003_tb05730_x
crossref_primary_10_1111_j_1600_0404_1990_tb01586_x
crossref_primary_10_1007_BF02535267
crossref_primary_10_1016_0006_291X_83_91572_3
crossref_primary_10_1016_0021_9150_87_90049_9
crossref_primary_10_1016_S0140_6736_82_90696_1
crossref_primary_10_1016_0024_3205_88_90356_6
crossref_primary_10_1016_S0140_6736_83_92871_4
crossref_primary_10_1016_S0049_3848_00_00313_3
crossref_primary_10_1016_S0022_2275_20_34324_8
crossref_primary_10_1042_CS20040119
crossref_primary_10_1021_acs_molpharmaceut_8b01065
crossref_primary_10_1186_s41043_023_00489_w
crossref_primary_10_1007_BF00844780
crossref_primary_10_1016_0021_9150_91_90081_D
crossref_primary_10_7759_cureus_15556
crossref_primary_10_1016_j_atherosclerosis_2004_10_010
crossref_primary_10_1016_S0022_3476_05_81666_X
crossref_primary_10_1007_BF02534720
crossref_primary_10_1093_ajcn_52_2_300
crossref_primary_10_1056_NEJM198604103141501
crossref_primary_10_1038_ki_1984_137
crossref_primary_10_1093_jn_133_7_2210
crossref_primary_10_1111_j_1753_4887_1989_tb02754_x
crossref_primary_10_1111_j_1753_4887_1986_tb07603_x
crossref_primary_10_1136_ard_45_12_1019
crossref_primary_10_1007_BF00915039
crossref_primary_10_1007_BF00877326
crossref_primary_10_1007_s11745_997_0089_x
crossref_primary_10_1016_0049_3848_89_90137_0
crossref_primary_10_1056_NEJM198809223191201
crossref_primary_10_1046_j_1365_201X_2003_01139_x
crossref_primary_10_1016_0163_7827_92_90009_8
crossref_primary_10_1111_j_0954_6820_1983_tb03705_x
crossref_primary_10_1093_ajcn_54_4_689
crossref_primary_10_1111_j_1365_2796_1989_tb01442_x
crossref_primary_10_1079_PNS19850064
crossref_primary_10_1017_S0007114598001068
crossref_primary_10_1016_0952_3278_93_90184_X
crossref_primary_10_1111_j_1749_6632_1997_tb51845_x
crossref_primary_10_1016_S0271_5317_83_80095_5
crossref_primary_10_1016_0049_3848_84_90249_4
crossref_primary_10_1079_BJN19940109
crossref_primary_10_1093_ajcn_54_3_438
crossref_primary_10_1016_0021_9150_85_90091_7
crossref_primary_10_1002_art_1780290412
crossref_primary_10_1016_S0022_2275_20_38310_3
crossref_primary_10_1111_j_1365_2796_1991_tb00353_x
crossref_primary_10_1016_S0271_5317_05_80344_6
crossref_primary_10_1007_BF02535173
crossref_primary_10_1016_S0889_8529_18_30328_1
crossref_primary_10_1016_0049_3848_90_90069_O
crossref_primary_10_1177_014860719301700130
crossref_primary_10_1079_BJN19920074
crossref_primary_10_1016_0952_3278_93_90074_7
crossref_primary_10_1079_BJN19880070
crossref_primary_10_1016_S0140_6736_87_90502_2
crossref_primary_10_1093_ajcn_43_4_566
crossref_primary_10_1016_S0025_6196_12_61879_5
crossref_primary_10_1016_0026_0495_95_90111_6
crossref_primary_10_1016_S0378_4347_00_80630_1
crossref_primary_10_1007_s00276_020_02596_3
crossref_primary_10_1093_ajcn_87_4_912
crossref_primary_10_1093_jn_118_6_661
crossref_primary_10_1016_0005_2760_95_00043_C
crossref_primary_10_1016_0952_3278_93_90112_A
crossref_primary_10_2740_jisdh_22_277
crossref_primary_10_1007_BF01966147
crossref_primary_10_1093_ajcn_55_3_760a
crossref_primary_10_1016_S0021_9150_98_00233_0
crossref_primary_10_1093_ajcn_54_4_668
crossref_primary_10_1111_j_1432_1033_1991_tb15842_x
crossref_primary_10_1016_0009_8981_87_90306_8
crossref_primary_10_1111_j_1365_2796_1989_tb01447_x
crossref_primary_10_1111_j_1445_5994_1988_tb00160_x
crossref_primary_10_1016_0049_3848_82_90112_8
crossref_primary_10_1007_BF02637095
crossref_primary_10_1007_BF02005181
crossref_primary_10_1111_nure_12071
crossref_primary_10_1016_0306_9877_87_90102_2
crossref_primary_10_1007_BF01622867
crossref_primary_10_1016_0021_9150_91_90233_S
crossref_primary_10_1007_BF02536438
crossref_primary_10_1016_0006_2952_94_90118_X
crossref_primary_10_1016_0006_2952_91_90445_B
crossref_primary_10_1111_j_1365_2141_1984_tb06103_x
crossref_primary_10_1111_j_1445_5994_1984_tb03613_x
crossref_primary_10_1093_ajcn_39_6_975
crossref_primary_10_1007_BF01907412
crossref_primary_10_1016_0305_0491_89_90225_3
crossref_primary_10_1007_BF02542556
crossref_primary_10_1016_0735_1097_93_90357_7
crossref_primary_10_1016_S0271_5317_85_80016_6
crossref_primary_10_1016_S0022_5223_19_38784_7
crossref_primary_10_1016_0005_2760_86_90266_3
crossref_primary_10_1016_S0952_3278_96_90072_1
crossref_primary_10_1111_j_1365_2796_1989_tb01436_x
crossref_primary_10_1016_0002_9149_90_91093_L
crossref_primary_10_1056_NEJM198610023151401
crossref_primary_10_1016_S0005_2760_97_00194_X
crossref_primary_10_1016_S0140_6736_89_90370_X
crossref_primary_10_1177_1060028087021007_803
crossref_primary_10_1056_NEJM199003223221202
crossref_primary_10_1016_0049_3848_90_90190_N
crossref_primary_10_1016_S0006_291X_83_80254_X
crossref_primary_10_1016_0026_0495_83_90226_3
crossref_primary_10_1002_ajh_2830240205
crossref_primary_10_1079_BJN19830123
crossref_primary_10_1093_jn_120_4_325
crossref_primary_10_1007_BF02536337
crossref_primary_10_1016_0090_6980_86_90123_1
crossref_primary_10_1080_07315724_1989_10720312
crossref_primary_10_1016_S0022_2275_20_37132_7
crossref_primary_10_1079_BJN19840069
crossref_primary_10_3390_sports7070167
crossref_primary_10_1093_ajcn_57_1_59
crossref_primary_10_1016_S0006_2952_96_00734_4
crossref_primary_10_1016_j_plipres_2008_03_003
crossref_primary_10_1111_j_1365_2796_1989_tb01448_x
crossref_primary_10_1016_0005_2760_92_90058_4
crossref_primary_10_1093_ajcn_46_3_424
crossref_primary_10_1007_BF00264763
crossref_primary_10_1007_BF02536338
crossref_primary_10_1093_jn_117_6_1011
crossref_primary_10_1007_BF01907750
crossref_primary_10_1016_0026_0495_85_90135_0
crossref_primary_10_1079_PNS19970049
crossref_primary_10_1111_j_1749_6632_1992_tb17102_x
crossref_primary_10_1136_hrt_57_3_214
crossref_primary_10_1016_0952_3278_91_90191_7
crossref_primary_10_1016_S0003_4975_10_64496_7
crossref_primary_10_1007_BF02536203
crossref_primary_10_1007_BF02533970
crossref_primary_10_1111_j_1440_1681_1991_tb01442_x
crossref_primary_10_3390_nu16091261
crossref_primary_10_1185_03007999309111542
crossref_primary_10_2740_jisdh_23_77
crossref_primary_10_1016_0006_291X_88_90737_1
crossref_primary_10_1002_bms_1200120905
crossref_primary_10_1016_0021_9150_87_90113_4
crossref_primary_10_1007_BF02522617
crossref_primary_10_1016_0091_7435_91_90065_C
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U7
C1K
7X8
DOI 10.1042/cs0610317
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Toxicology Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1470-8736
EndPage 324
ExternalDocumentID 6266735
10_1042_cs0610317
Genre Journal Article
GroupedDBID ---
.55
.GJ
0R~
0VX
3O-
53G
5GY
5RE
5VS
6J9
AAYXX
ABCQX
ABJNI
ACGFO
ACGFS
AEGXH
AENEX
AFFNX
AI.
AIAGR
AIZAD
ALMA_UNASSIGNED_HOLDINGS
CITATION
CS3
DU5
EBS
EJD
F5P
GX1
H13
HZ~
L7B
MVM
O9-
OHT
P2P
RHI
RPO
VH1
WH7
X7M
ZGI
ZXP
29B
2WC
4.4
AABGO
AAHRG
ADBBV
AFFVI
BAWUL
CGR
CUY
CVF
E3Z
EBD
ECM
EIF
EMOBN
MV1
NPM
NTEUP
P6G
SV3
TR2
7U7
C1K
7X8
ID FETCH-LOGICAL-c292t-71c8d148196837b46bbb916fa6d2103e30122ae5e2114b27ea249b938f4b372f3
ISSN 0143-5221
IngestDate Fri Jul 11 07:06:22 EDT 2025
Fri Jul 11 07:41:10 EDT 2025
Sat Sep 28 08:34:27 EDT 2024
Thu Apr 24 23:05:27 EDT 2025
Tue Jul 01 03:56:56 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c292t-71c8d148196837b46bbb916fa6d2103e30122ae5e2114b27ea249b938f4b372f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 6266735
PQID 15358598
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_73581011
proquest_miscellaneous_15358598
pubmed_primary_6266735
crossref_primary_10_1042_cs0610317
crossref_citationtrail_10_1042_cs0610317
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1981-Sep
PublicationDateYYYYMMDD 1981-09-01
PublicationDate_xml – month: 09
  year: 1981
  text: 1981-Sep
PublicationDecade 1980
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical science (1979)
PublicationTitleAlternate Clin Sci (Lond)
PublicationYear 1981
SSID ssj0023232
Score 1.5223904
Snippet 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g...
1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and...
Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1 multiplied by 8 g of eicosapentaenoic acid (20:5...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 317
SubjectTerms Adult
Bleeding Time
Blood Platelets - metabolism
Carotenoids - blood
Cholesterol - blood
Cod Liver Oil - pharmacology
Docosahexaenoic Acids
Eicosanoic Acids - pharmacology
Eicosapentaenoic Acid
Erythrocytes - metabolism
Fatty Acids, Unsaturated - pharmacology
Fish Oils - pharmacology
Glycerophosphates - blood
Hemostasis - drug effects
Humans
Lipids - blood
Male
Platelet Aggregation - drug effects
Triglycerides - blood
Vitamin A - blood
Title Effect on Blood Lipids and Haemostasis of a Supplement of Cod-Liver Oil, Rich in Eicosapentaenoic and Docosahexaenoic Acids, in Healthy Young Men
URI https://www.ncbi.nlm.nih.gov/pubmed/6266735
https://www.proquest.com/docview/15358598
https://www.proquest.com/docview/73581011
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIgL4lWxPC3EASkNNLY3j2OFWipUyoFdtLfIThw10jZZka3U9l_wj_n8SHa3tOJxiXYdx4k8n8bzjWfGhLwts1RFlcrCkgsRinSchlKLJIzSqoxYpc2iYqItjuPDqfg8G89W8fM2u2Sp3heX1-aV_I9U0Qa5mizZf5DsMCga8BvyxRUSxvWvZOxLD0OANv48mNeLunRFl0-kPm1h-fl6IzLozPGdut_6L9oynJuQjKB1TmCoQ-v70EBGJxcmolw3rS_mWram8USf920FXmOewgMukfIiuDBqIzj1mWV97YONvMvC2rNRlmRr_odvLr3G4mblWP1em3CPbtNdK2t_rsCez0orXfpeGg3hWCsHJgf5dVnRvQaOozWk8TV1yl1e529qHpoGsik6GCO7vs9mKe3jr_nB9Ogon-zPJrfJHZYkdg__02yI_4ElaU-vGz6oLzsl2Idh4E1j5QYGYi2RyQNy31MIuufw8JDc0s0jcveLD5J4TH46WNC2oRYW1MGCYqLpGixoW1FJV7Aw_wdYUMBihxpQ0LqhV0Fhh7oCCmpBsWO6e0hQCwmKsZ-Q6cH-5ONh6E_eCAuWsWWYREVagihDPac8USJWSoFHVDIuGSZGc7MhK_VYM9BpxRItweJVxtNKKJ6wim-TraZt9FNCdQoGjvsMVEMYvhBzHWcizhTXoEzViLzrpzgvfFl6czrKPLfhEYLlgzRG5M3QdeFqsVzX6XUvpxya0mx_yUa3Z12OtR3cOEtv7pGYYoBY8EZk2wl4eA1of4y7z_746HNybwX7F2Rr-eNMv4TZulSvLPx-AbD9mhw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+on+blood+lipids+and+haemostasis+of+a+supplement+of+cod-liver+oil%2C+rich+in+eicosapentaenoic+and+docosahexaenoic+acids%2C+in+healthy+young+men&rft.jtitle=Clinical+science+%281979%29&rft.au=Sanders%2C+T+A&rft.au=Vickers%2C+M&rft.au=Haines%2C+A+P&rft.date=1981-09-01&rft.issn=0143-5221&rft.volume=61&rft.issue=3&rft.spage=317&rft_id=info:doi/10.1042%2Fcs0610317&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-5221&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-5221&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-5221&client=summon